Member Info for Toukankahmoon

Bein

You know nothing about me.

Avacta is a small part of my investments and getting smaller by the day!

I’ve just sold one of my classic cars for more than I’ve lost on Avacta and I certainly won’t be investing the profits in Avacta.

What RNS?

You’ve been told all you need to know about today’s EGM

The sell off is well underway. At least that means there won’t be a rush for others to sell tomorrow.

Notrex

Abx did what they were supposed to do. The LFT design was Avacta’s not Abingdon’s

Let’s hope it’s better than previous efforts. I won’t hold my breath.

Cj62 and Stodgy

Unlike some others I don’t stay on this BB all day. I come on for 10 mins is so when I can and reply to any thread that is good new info or ridiculous wishful thinking. Sadly at the moment it’s mostly the latter.

And that is why I challenged this ridiculous notion that keeps getting regurgitated about the trial data being better than expected. A complete f**king nonsense. It is no better than what the rat trials signalled it should be.

JT

In what way has the trial been better than we dared expect? Fantasists keep saying this but the trial results are no better than the rat trials and I have to believe that Avacta expected human trials to yield similar results.

Sort of puts it in perspective.

Also funny to read Icecool’s post below it 🤣

What is a post marketing trial?

. . . or could it be that there is just no news?

Gje306

I stand corrected.

Captains

Shows what a liar you are. Cut and paste the post where I predicted 20p. I’ve never said that though I’ve frequently challenged those that have said £20 next week.

I was expecting FOMO Friday but now I’ve missed the opportunity to sell at 56p earlier in the week.

I admire your continuing optimism especially given what has happened over the last year. Though you do say “if”.

AACR will just present December data. Nothing of significance has happened since then.

How have you drawn that conclusion?

WeareGroot

I love to see people say it’s not Al’s fault that AVA6000 is more successful than he expected.

What? So he didn’t expect it to work as well in humans as it did in rats? He didn’t realise that because there was little escape of dox into the main bloodstream that OMD would be at a huge dose level.

And he’s an excellent scientist. Do stop all this excuse making.

. . . and still the fantasists ramp on about NDAs and the like stopping us from hearing about the exceptional results and incoming deals.

You don’t get it do you? There will be no news until Arm 2 data is published.

GOz

For this to be the success we want it to be, it is going to have to shrink tumours and not in just 3 out of 40 patients

Gosushi

I’m with you. EGM will just be formality to get raise agreed. No progress report. No new data.

AAACR will not provide new data.

Next pivotal moment will be when arm2 data is released in 3Q24 maybe

Timster

Please shut up about the ribena scare. It isn’t funny neither is it an accurate reflection of my concerns about AVA6000 efficacy.

I’ve asked you several times what your take is on the events of last six months and how (based on fact not wishful thinking) you expect things to play out. And all you do is p*ss about.

I think HOLD is the best option for next few months to see how things work out. I don’t want to sell on current paper loss and buying more right now when we don’t know what issues are being worked on to get this right is only for greedy people with deep pockets

Banerji would be there anyway even he wasn’t presenting for Avacta. It’s one of the most important oncology shindigs. He needs to meet up with his mates and see what else is going on.